Small cell lung cancer (SCLC) is a neuroendocrine lung cancer strongly linked to tobacco exposure. It accounts for about 15% of lung cancers, with roughly 150,000 new diagnoses worldwide each year. For decades, it has […]
Clinical Background Small-cell lung cancer (SCLC) accounts for about 15 % of all lung cancers and is one of the most aggressive types because it grows rapidly and spreads early. It is classified as limited […]
Understanding the Role of Ferritin in CAR-T Therapy Outcomes Multiple myeloma is a complex and often aggressive cancer of plasma cells. When standard treatments no longer work—such as after chemotherapy, immunotherapy, or stem cell transplantation—the […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH